The Director of "Vector" to investigate the vaccine COVID will begin on volunteers

Clinical studies of the vaccine against coronavirus in the center "Vector" will start with a group of 10 people aged 18 to 30 years, and later in the study will involve volunteers under the age of 60 years, said in an interview with RIA Novosti Director of the center for Rinat Maksyutov.

He noted that the decision about vaccination for the population can be taken only after final confirmation of safety and efficacy of the vaccine, its registration.

Earlier, Deputy Prime Minister of the Russian Federation Tatyana Golikova called the center "Vector" one of the leaders in creating a vaccine against coronavirus.

Relevant data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.